Zhao Hongxing, Wu Kangzhong
Department of Radiology, First Affiliated Hospital of Huzhou University Huzhou 313000, Zhejiang, China.
Department of General Surgery, First Affiliated Hospital of Huzhou University Huzhou 313000, Zhejiang, China.
Am J Transl Res. 2024 May 15;16(5):2070-2081. doi: 10.62347/NYHH3132. eCollection 2024.
Hyperglycemic status is associated with the development and prognosis of colorectal cancer (CRC), although the exact mechanisms are not fully understood. Hyperglycemia can promote the development of CRC by influencing cell proliferation and apoptosis, inflammatory responses, oxidative stress, immunomodulation, angiogenesis, and other pathways. In terms of prognosis, hyperglycemia may affect the survival and recurrence of CRC patients as well as chemotherapy resistance, but the results of related studies are not consistent. Hypoglycemic treatment may have a positive impact on the prognosis of CRC patients, but its specific effects need further research. Therefore, this article systematically explores the relationship between hyperglycemia and CRC, analyzes the impact of hyperglycemia on the occurrence and prognosis of CRC, and discusses the role of managing hyperglycemia in CRC.
高血糖状态与结直肠癌(CRC)的发生发展及预后相关,尽管确切机制尚未完全明确。高血糖可通过影响细胞增殖与凋亡、炎症反应、氧化应激、免疫调节、血管生成及其他途径促进结直肠癌的发展。在预后方面,高血糖可能影响结直肠癌患者的生存、复发以及化疗耐药性,但相关研究结果并不一致。降糖治疗可能对结直肠癌患者的预后产生积极影响,但其具体效果有待进一步研究。因此,本文系统探讨高血糖与结直肠癌之间的关系,分析高血糖对结直肠癌发生及预后的影响,并讨论控制高血糖在结直肠癌中的作用。